Hostname: page-component-55f67697df-twqc4 Total loading time: 0 Render date: 2025-05-09T16:39:06.421Z Has data issue: false hasContentIssue false
  • English
  • Français

An 8-year single-centre experience of patients with subclinical rheumatic carditis

Published online by Cambridge University Press:  03 October 2024

Ahmet İrdem Open the ORCID record for Ahmet İrdem [Opens in a new window] ,
Selma Oktay Ergin ,
Alper Kaçar  and
Fatma Ece Dağdeviren
Ahmet İrdem*
Affiliation:
Faculty of Medicine, Department of Pediatric Cardiology, Çanakkale Onsekiz Mart University, Çanakkale, Turkey
Selma Oktay Ergin
Affiliation:
Department of Pediatric, İstanbul Prof. Dr Cemil Taşcıoğlu City Hospital, İstanbul, Turkey
Alper Kaçar
Affiliation:
Department of Pediatric, İstanbul Prof. Dr Cemil Taşcıoğlu City Hospital, İstanbul, Turkey
Fatma Ece Dağdeviren
Affiliation:
Department of Pediatric, İstanbul Prof. Dr Cemil Taşcıoğlu City Hospital, İstanbul, Turkey
*
Corresponding author: Ahmet İrdem; Email: [email protected]
Get access Rights & Permissions [Opens in a new window]

Abstract

Objective:

Transthoracic echocardiography is the gold standard method for screening and confirmation of acute rheumatic fever and subclinical rheumatic heart disease. Secondary antibiotic prophylaxis that is regularly employed in subclinical rheumatic heart disease may help to reverse mild rheumatic carditis lesions, delay the progression of the disease, reduce morbidity and mortality, and improve patients’ quality of life.

Materials and Methods:

We retrospectively evaluated the outcomes of 180 patients with subclinical rheumatic heart disease who were followed up for a mean of 4.92 ± 2.0 (3.5–6.5) years.

Results:

Between 1 March 2015 and 31 December 2023, 180 patients diagnosed with subclinical rheumatic heart disease with a mean follow-up of 4.92 ± 2.0 (3.5–6.5) years were included in the study. Of the patients, 50.6% were male, 49.4% were female, mean age at diagnosis was 11.74 ± 3.18 (9.68–13.65) years, and mean follow-up period was 4.92 ± 2.0 (3.5–6.5) years. Further, 87.2 % of the patients had mitral valve regurgitation, 38.3% had aortic valve regurgitation, and 27.2% had both valve (aortic and mitral valve) regurgitation. Moreover, Sydenham chorea was also diagnosed in 7.8% the patients. Of the patients, 90% had mild rheumatic heart disease, 7.8% had moderate rheumatic heart disease, and 2.2% had severe rheumatic heart disease. After the diagnosis of rheumatic heart disease, 76.7% patients received regular and 23.3% irregular secondary benzathine penicillin G prophylaxis.

Conclusion:

We believe that echocardiography demonstrates its efficacy and safety profile in reducing the risk of rheumatic heart disease in patients diagnosed with subclinical rheumatic carditis and complying with regular secondary antibiotic prophylaxis.

Keywords

childrensecondary prophylaxissubclinic rheumatic carditis
Type
Original Article
Information
Cardiology in the Young , Volume 34 , Issue 12 , December 2024 , pp. 2521 - 2527
Check for updates
Copyright
© The Author(s), 2024. Published by Cambridge University Press

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Article purchase

Temporarily unavailable

References

Bisno, AL. Group A streptococcal infections and acute rheumatic fever. N Engl J Med 1991; 325, 783–793. DOI: 10.1056/NEJM199109123251106.CrossRefGoogle ScholarPubMed
Gewitz, MH, Baltimore, RS, Tani, LY, American Heart Association Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease of the Council on Cardiovascular Disease in the Young. Revision of the Jones Criteria for the diagnosis of acute rheumatic fever in the era of doppler echocardiography. Circulation 2015; 131, 1806–1818. DOI: 10.1161/CIR.0000000000000205.CrossRefGoogle Scholar
Zühlke, LJ, Beaton, A, Engel, ME et al. Group a streptococcus, acute rheumatic fever and rheumatic heart disease: epidemiology and clinical considerations. Curr Treat Options Cardiovasc Med 2017; 19, 15. DOI: 10.1007/s11936-017-0513-y.CrossRefGoogle ScholarPubMed
Lawrence, JG, Carapetis, JR, Griffiths, K, Edwards, K, Condon, JR. Acute rheumatic fever and rheumatic heart disease: incidence and progression in the Northern Territory of Australia, 1997 to 2010. Circulation 2013; 128, 492–501. DOI: 10.1161/CIRCULATIONAHA.113.CrossRefGoogle ScholarPubMed
Karthikeyan, G, Guilherme, L. Acute rheumatic fever. Lancet 2018; 392, 161–174. DOI: 10.1016/S0140-6736(18)30999-1.CrossRefGoogle ScholarPubMed
Reményi, B, Wilson, N, Steer, A et al. World Heart Federation criteria for echocardiographic diagnosis of rheumatic heart disease--an evidence-based guideline. Nat Rev Cardiol 2012; 9, 297–309. DOI: 10.1038/nrcardio.2012.7.CrossRefGoogle ScholarPubMed
Gerber, MA, Baltimore, RS, Eaton, CB et al. Prevention of rheumatic fever and diagnosis and treatment of acute Streptococcal pharyngitis: a scientific statement from the American Heart Association Rheumatic Fever,Endocarditis, and Kawasaki Disease Committee of the Council on Cardiovascular Disease in the Young, the Interdisciplinary Council on Functional Genomics and Translational Biology, and the Interdisciplinary Council on Quality of Care and Outcomes Research: endorsed by the American Academy of Pediatrics. Circulation 2009; 119, 1541–1551. DOI: 10.1161/CIRCULATIONAHA.109.CrossRefGoogle Scholar
Iung, B, Vahanian, A, Iung, B, Vahanian, A. Epidemiology of acquired valvular heart disease, Epidemiology of acquired valvular heart disease. Can J Cardiol 2014; 30, 962–970. DOI: 10.1016/j.cjca.2014.03.022.CrossRefGoogle ScholarPubMed
Murphy, A, Woodman, M, Roberts, B, McKee, M. The neglected refugee crisis. BMJ 2016;352. DOI: 10.1136/bmj.i484.Google ScholarPubMed
Pandian, NG, Kim, JK, Arias-Godinez, JA et al. Recommendations for the use of Echocardiography in the evaluation of Rheumatic Heart Disease: a report from the American Society of Echocardiography. J Am Soc Echocardiogr 2023; 36, 3–28. DOI: 10.1016/j.echo.2022.10.009.CrossRefGoogle ScholarPubMed
Araújo, FD, Goulart, EM, Meira, ZM. Prognostic value of clinical and Doppler echocardiographic findings in children and adolescents with significant rheumatic valvular disease. Ann Pediatr Cardiol 2012; 5, 120–126. DOI: 10.4103/0974-2069.99610.Google ScholarPubMed
Karthikeyan, G. Diagnosis of acute rheumatic carditis: An echo in time. Ann Pediatr Cardiol 2012, 5, 127–128.CrossRefGoogle ScholarPubMed
Tubridy-Clark, M, Carapetis, JR. Subclinical carditis in rheumatic fever: a systematic review. Int J Cardiol 2007; 119, 54–58. DOI: 10.1016/j.ijcard.2006.07.046.CrossRefGoogle ScholarPubMed
Beaton, A, Okello, E, Rwebembera, J et al. Secondary Antibiotic Prophylaxis for Latent Rheumatic Heart Disease. N Engl J Med 2022; 386, 230–240. DOI: 10.1056/NEJMoa2102074.CrossRefGoogle ScholarPubMed
Marijon, E, Ou, P, Celermajer, DS et al. Prevalence of rheumatic heart disease detected by echocardiographic screening. N Engl J Med 2007; 357, 470–476. DOI: 10.1056/NEJMoa065085.CrossRefGoogle ScholarPubMed
Lamichhane, P, Patel, F, Al Mefleh, R et al. Detection and management of latent rheumatic heart disease: a narrative review. Ann Med Surg (Lond) 2023; 85, 6048–6056. DOI:10.1097/MS9.CrossRefGoogle ScholarPubMed
Kevat, PM, Gunnarsson, R, Reeves, BM, Ruben, AR. Adherence rates and risk factors for suboptimal adherence to secondary prophylaxis for rheumatic fever. J Paediatr Child Health 2021; 57, 419–424. DOI: 10.1111/jpc.15239.CrossRefGoogle ScholarPubMed
Liang, Y, Yu, D, Lu, Q, Zheng, Y, Yang, Y. The rise and fall of acute rheumatic fever and rheumatic heart disease: a mini review. Front Cardiovasc Med 2023; 10, 1183606–1183606. DOI: 10.3389/fcvm.2023.CrossRefGoogle ScholarPubMed
Beaton, A, Okello, E, Aliku, T et al. Latent rheumatic heart disease: outcomes 2 years after echocardiographic detection. Pediatr Cardiol 2014; 35, 1259–1267. DOI: 10.1007/s00246-014-0925-3.CrossRefGoogle ScholarPubMed
Hunter, LD, Monaghan, M, Lloyd, G, Pecoraro, AJK, Doubell, AF, Herbst, PG. Screening for rheumatic heart disease: is a paradigm shift required? Echo Res Pract 2017; 4, R43–R52. DOI: 10.1530/ERP-17-0037.CrossRefGoogle ScholarPubMed
Wyber, R, Grainger Gasser, A, Thompson, D et al. Tools for implementing RHD Control Programmes (TIPS) handbook. World Heart Federation and RhEACH, Perth, Australia, 2014.Google Scholar
Remenyi, B, Carapetis, J, Wyber, R, Taubert, K, Mayosi, BM, World Heart, F. Position statement of the World Heart Federation on the prevention and control of rheumatic heart disease. Nat Reviews Cardiol 2013; 10, 284–292. DOI: 10.1038/nrcardio.2013.34.CrossRefGoogle ScholarPubMed
Bottomley, A, Jones, D, Claassens, L. Patient-reported outcomes: assessment and current perspectives of the guidelines of the Food and Drug Administration and the reflection paper of the European Medicines Agency. Eur J Cancer 2009; 45, 347–353. DOI: 10.1016/j.ejca.2008.09.032.CrossRefGoogle ScholarPubMed
Fareed, A, Saleh, O, Maklady, F. Screening for the prevalence of rheumatic heart disease among school children in Egypt. Echocardiography 2023; 40, 494–499. DOI: 10.1111/echo.15580.CrossRefGoogle ScholarPubMed
Chillo, P, Mutagaywa, R, Nkya, D et al. Sub-clinical rheumatic heart disease (RHD) detected by hand-held echocardiogram in children participating in a school-based RHD prevention program in Tanzania. BMC Cardiovasc Disord 2023, 23, 155. DOI: 10.1186/s12872-023-03186-y.CrossRefGoogle Scholar
Engel, ME, Haileamlak, A, Zuhlke, L et al. Prevalence of rheumatic heart disease in 4720 asymptomatic scholars from South Africa and Ethiopia. Heart 2015; 101, 1389–1394. DOI: 10.1136/heartjnl-2015-307444.CrossRefGoogle ScholarPubMed
Yadeta, D, Hailu, A, Haileamlak, A et al. Prevalence of rheumatic heart disease among school children in Ethiopia: a multisite echocardiography-based screening. Int J Cardiol 2016; 221, 260–263. DOI: 10.1016/j.ijcard.2016.06.232.CrossRefGoogle Scholar
Beaton, A, Okello, E, Lwabi, P, Mondo, C, McCarter, R, Sable, C. Echocardiography screening for rheumatic heart disease in ugandan schoolchildren. Circulation 2012; 125, 3127–3132. DOI: 10.1161/CIRCULATIONAHA.112.CrossRefGoogle ScholarPubMed
Marijon, E, Celermajer, DS, Tafflet, M et al. Rheumatic heart disease screening by echocardiography: the inadequacy of World Health Organization criteria for optimizing the diagnosis of subclinical disease. Circulation 2009; 120, 663–668. DOI: 10.1161/CIRCULATIONAHA.109.849190.CrossRefGoogle ScholarPubMed
Dougherty, S, Khorsandi, M, Herbst, P. Rheumatic heart disease screening: Current concepts and challenges. Ann Pediatr Cardiol 2017; 10, 39–49. DOI: 10.4103/0974-2069.197051.CrossRefGoogle Scholar
https://data.tuik.gov.tr/Bulten/Index?p=Istatistiklerle-Cocuk-2022-49674.Google Scholar
Marques-Dias, MJ, Mercadante, MT, Tucker, D, Lombroso, P. Sydenham ’s chorea. Psychiatr Clin North Am 1997; 20, 809–820. DOI: 10.1016/s0193-953x(05)70346-4.CrossRefGoogle ScholarPubMed
Orsini, A, Foiadelli, T, Magistrali, M et al. A nationwide study on Sydenham’s chorea: clinical features, treatment and prognostic factors. Eur J Paediatr Neurol 2022; 36: 1–6. DOI: 10.1016/j.ejpn.2021.11.002.CrossRefGoogle Scholar
A.Ibrahim, EA, Mohamed, RH, Abbasher Hussien Mohamed Ahmed, K, AbdAlla Mohamed, MT, Fadelallah Eljack, MM. Sydenham Chorea in Sudan; Presentation Panorama. Neuropsychiatr Dis Treat, 2023; 19: 1657–1663. DOI: 10.2147/NDT.CrossRefGoogle ScholarPubMed
Soller, T, Roberts, KV, Middleton, BF, Ralph, AP. Sydenham chorea in the top end of Australia’s Northern Territory: a 20-year retrospective case series. J Paediatr Child Health 2023; 59, 1210–1216. DOI: 10.1111/jpc.16481.CrossRefGoogle ScholarPubMed
Lue, HC, Wu, MH, Wang, JK, Wu, FF, Wu, YN. Long-term outcome of patients with rheumatic fever receiving benzathine penicillin G prophylaxis every three weeks versus every four weeks. J Pediatr 1994; 125, 812–816. DOI: 10.1016/s0022-3476(94)70082-6.CrossRefGoogle ScholarPubMed
Carapetis, JR, Beaton, A, Cunningham, MW et al. Acute rheumatic fever and rheumatic heart disease. Nat Rev Dis Primers 2016; 2, 15084. DOI: 10.1038/nrdp.2015.84.CrossRefGoogle ScholarPubMed
Katzenellenbogen, JM, Ralph, AP, Wyber, R, Carapetis, JR. Rheumatic heart disease: infectious disease origin, chronic care approach. BMC Health Serv Res 2017; 17, 793. DOI: 10.1186/s12913-017-2747-5.CrossRefGoogle ScholarPubMed
Zühlke, L, Engel, ME, Lemmer, CE et al. The natural history of latent rheumatic heart disease in a 5 year follow-up study: a prospective observational study. BMC Cardiovasc Disord 2016; 16,46. DOI: 10.1186/s12872-016-0225-3.CrossRefGoogle Scholar
Fall, N, Odong, F, Thembo, J et al. User-centered design to develop automated short message service messaging for patient support of Rheumatic Heart Disease Secondary Antibiotic Prophylaxis. J Am Heart Assoc 2024; 13, e031252. DOI: 10.1161/JAHA.123.CrossRefGoogle ScholarPubMed